CD8+ T Cells Protect During Vein Graft Disease Development

Area of Science:

• Immunology
• Cardiovascular Surgery
• Vascular Biology

Background:

• Vein grafts are crucial for arterial reconstruction in cardiovascular disease.
• Vein graft disease (VGD) significantly reduces graft patency.
• The role of T cells in VGD remains largely unknown.

Purpose of the Study:

• To investigate the role of T cells in VGD.
• To elucidate T cell activation pathways involved in VGD, including T cell receptor (TCR), co-stimulation, and bystander effects.

Main Methods:

• Vein graft surgery was performed in mice depleted of CD4+ or CD8+ T cells.
• Analysis of vein graft patency, apoptosis, and T cell activation markers.
• Studies utilized genetically modified mice lacking specific TCR, co-stimulatory molecules (CD70, CD80/86), or cytokines.

Main Results:

• CD8+ T cells demonstrated a significant protective role in maintaining vein graft patency.
• Depletion of CD8+ T cells led to graft occlusion and increased apoptosis.
• The protective effect of CD8+ T cells was independent of TCR and co-stimulation signaling.
• Up-regulation of cytokines (IL-15, IL-18, IL-33, TNF) facilitated bystander activation of CD8+ T cells.

Conclusions:

• T cells modulate VGD, with CD8+ T cells playing a specific protective role.
• CD8+ T cells are activated locally within vein grafts.
• Protection against occlusive lesions is mediated by CD8+ T cells through survival signals, independent of TCR and co-stimulation.